Building on Solid Achievements
MicrosensDx is a dynamic and ambitious organisation, built from a solid base back in 2001.
With three patent families covering sample preparation, protein aggregation and inflammation/sepsis, MicrosensDx is driven to produce innovative products that enhance patient management and ultimately improve health outcomes.
During the Covid pandemic, MicrosensDx responded rapidly to market demand with a 30 minute, near patient testing platform utilising LAMP technology. This was supported by our RapiPREP Nucleic Acid extraction reagents. Prior to this, the companies protein aggregation IP for BSE (Mad Cow Disease) has been licensed to a global veterinary health company where it has enabled thousands of cattle to be tested.
The future focus of the company is around further development of our RapiPREP sample preparation technology and inflammation and sepsis diagnostics.
Empowering results with Sample Handling and Diagnostics Expertise
We are driven by delivering high quality products which are based on the requirements of patients, clinicians and clinical laboratory professionals. This means that we provide what is needed from a performance point of view but also ensuring ease of use to allow a fast streamlined workflow.
Our Company values are based on trust, mutual respect, providing choice, collaboration and scientific excellence thus ensuring confidence in the results delivered by our products.
Laboratory Efficiency Assessment Framework (LEAF)